Hedera
HBAR
Fundamental comparison between Hedera and Injective
Not Financial Advice
This page is an informational analysis, not investment advice. The CryptoValue Score is an algorithmically generated rating from public data — it does not replace professional advice. Cryptocurrencies are highly volatile; total loss is possible. Read full risk disclaimer →
Hedera
Coverage: 11/13 · 84%
Calculated:
Injective
Coverage: 10/13 · 74%
Calculated:
Detailed Comparison
| Metric | Hedera | Injective |
|---|---|---|
| Price | $0.069507 | $7.22 |
| Market Cap | $3.08B | $722.03M |
| 24h Volume | 42.8M | 69.7M |
| Rank | #33 | #87 |
| Circulating Supply | 44.3B | 100M |
| ATH | $0.569229 | $52.62 |
Hedera vs Injective — Analysis
Comparison of Hedera and Injective: published market readings and a Value Score using up to 13 model components. Sourced project profiles add purpose, token role and risks where available.
Value Score Comparison
Hedera: 61.1/100; Injective: 76.5/100. No direct score comparison: data coverage differ or are unrecorded.
Market Capitalization
Hedera has 4.27 times the market capitalization of Injective. This ratio measures market size; it does not establish volatility or future returns.
Price Performance
Reported price change over 24 hours: Hedera -0.36%, Injective 3.25%. Over 7 days: Hedera -8.34%, Injective -10.85%. Missing readings are shown as —.
Distance from All-Time High
Hedera trades at 12.21% of its reported all-time high; Injective at 13.72%. This distance describes price history and is not a standalone buy signal.
Conclusion
The readings show differences in market value and model assessment. Project purpose, token rights, risks, source dates and data coverage also matter. A higher score does not predict higher returns or lower risk.